Journal of Clinical Oncology · 2013 · 21 citations · 22 references
MedicineOncologyPathologyCancer ImmunologyMolecular VirologyVirologyFollicular DisordersLymph Node PathologyLymphoid NeoplasmsLymphoid TumorsDna In Situ HybridizationEpstein-barr Virus - Associated Lymphoid NeoplasmsEpstein-barr Virus - Associated MalignanciesEpstein-barr Virus PersistenceFollicular Lymphoma BiologyGeneralized LymphadenopathyLymphoma StagingPrednisone Use
A 53-year-old white woman with generalized lymphadenopathy was diagnosed with follicular lymphoma, grades 1 to 2, stage III. Three months later, she was started on six cycles of rituximab, cyclophosphamide, vincristine, and prednisone therapy with minimal response. A repeat lymph node biopsy approximately 1 year later revealed persistent follicular lymphoma (grades 1 to 2) after which the patient received six cycles of bendamustine therapy. Epstein-Barr virus (EBV)-encoded RNA in situ hybridization (EBER-ISH) on the lymph node biopsy failed to demonstrate EBV infection.
22